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Photochemotherapy, the combination of a photosensitiser and ultraviolet (UV) or visible light, is an effec-
tive treatment for skin conditions including cancer. The high mutagenicity and non-selectivity of pho-
tochemotherapy regimes warrants the development of alternative approaches. We demonstrate that
the thiopyrimidine nucleosides 5-bromo-4-thiodeoxyuridine (SBrdU) and 5-iodo-4-thiodeoxyuridine
(SIdU) are incorporated into the DNA of cultured human and mouse cells where they synergistically sen-
sitise killing by low doses of UVA radiation. The DNA halothiopyrimidine/UVA combinations induce DNA
interstrand crosslinks, DNA-protein crosslinks, DNA strand breaks, nucleobase damage and lesions that
resemble UV-induced pyrimidine(6-4)pyrimidone photoproducts. These are potentially lethal DNA
lesions and cells defective in their repair are hypersensitive to killing by SBrdU/UVA and SIdU/UVA.
DNA SIdU and SBrdU generate lethal DNA photodamage by partially distinct mechanisms that reﬂect
the different photolabilities of their C–I and C–Br bonds. Although singlet oxygen is involved in photole-
sion formation, DNA SBrdU and SIdU photoactivation does not detectably increase DNA 8-oxoguanine
levels. The absence of signiﬁcant collateral damage to normal guanine suggests that UVA activation of
DNA SIdU or SBrdU might offer a strategy to target hyperproliferative skin conditions that avoids the
extensive formation of a known mutagenic DNA lesion.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Many cancer therapies act by killing cells through the introduc-
tion of DNA damage. One of the major drawbacks of this therapeu-
tic approach is its indiscriminate nature, resulting in potentially
severe side effects including the development of therapy-induced
cancer. Photochemotherapy partially obviates this problem by
speciﬁcally targeting appropriately sensitised cancer cells with
light. The combination of a photosensitiser and ultraviolet or visi-
ble radiation to induce synergistic cytotoxicity is effective for many
skin conditions including psoriasis and cancer. Examples include
psoralen plus UVA (PUVA) – for psoriasis and cutaneous T cell lym-
phoma – and photodynamic therapy (PDT) which is effective
against head and neck and skin carcinomas (reviewed in [1]).
Although these established approaches are effective, their high
mutagenicity and association with cancer (PUVA) or pain and
non-selectivity for cancer tissue (PDT) frequently result in unsatis-
factory patient outcomes. Alternative therapies that combineenhanced selectivity for rapidly dividing cells and low radiation
doses are clearly desirable.
Canonical DNA nucleobases absorb maximally around 260 nm
and so have signiﬁcant absorbance at both UVB (280–315 nm)
and UVC (100–280 nm) wavelengths. UVB and UVC cause direct
DNA damage that is lethal and potentially carcinogenic [2]. Their
toxic effects are enhanced by the halopyrimidine deoxynucleosides
5-bromo-2’-deoxyuridine (BrdU) and 5-iodo-2’-deoxyuridine
(IdU). These non-toxic ionising radiation and UVB/UVC sensitisers
[3–5] are extensively used in various aspects of nucleic acid
research. Both 5-halo-2’-deoxynucleosides absorb maximally at
around 280 nm [6]. They are incorporated into the DNA of replicat-
ing cells where they interact synergistically with UVC or UVB to
generate potentially lethal DNA strand-breaks [7], DNA interstrand
crosslinks (ICLs) [8] and DNA-protein crosslinks (DPCs) [9].
In contrast to UVC and UVB, the less energetic, longer wave-
length UVA (315–400 nm) is absorbed very poorly by canonical
DNA bases and causes relatively little direct DNA damage [10].
DNA containing a UVA chromophore is, however, susceptible to
damage by normally harmless UVA doses. Hoechst 33258 dye, a
DNA-intercalating UVA chromophore, synergistically sensitises
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age spectrum induced by the Hoechst 33258/UVA combination in
cells containing DNA BrdU or IdU is similar to that generated by
UVB or UVC and includes strand breaks [11,12], base damage
[13] and ICLs [14]. The potential clinical utility of the DNA binding
bisbenzimidazoles like Hoechst 33258 is, however, limited by their
genotoxicity and mutagenicity [15].
Modiﬁcation of canonical nucleobases offers an alternative
strategy to introduce a UVA chromophore into DNA. The presence
of a sulphur atom shifts nucleobase absorbance maxima into the
UVA region (approximately 340 nm). S4-thiothymine (S4T) and 6-
thioguanine (6-TG) are UVA chromophores that can be extensively
incorporated into cellular DNA where they sensitise to killing by
normally harmless UVA doses. We have previously reported the
synthesis of the UVA chromophores 5-bromo-4-thio-2’-deoxyuri-
dine (SBrdU) [16] and 5-iodo-4-thio-2’-deoxyuridine (SIdU) [17].
Here we report that human cells can accumulate DNA SIdU and
SBrdU. Non-toxic levels of these DNA-embedded UVA chro-
mophores sensitise the formation of lethal DNA strand breaks, ICLs,
DPCs and DNA base lesions by UVA and obviate the requirement
for a DNA binding photosensitising dye.2. Materials and methods
2.1. Chemicals
Synthesis of 5-bromo-4-thio-2’-deoxyuridine (SBrdU) and 5-
iodo-4-thio-2’-deoxyuridine (SIdU) has been described previously
[16,17]. 4-Thio-2’-deoxyuridine (SdU) was purchased from Car-
bosynth and 2’-deoxyuridine (dU) from Sigma.
2.2. Cell culture
Cells were obtained from Clare Hall Laboratories Cell Services.
Wild type (F11.1) and ung/ mouse embryonic ﬁbroblasts (MEFs)
[18] were grown in 50% DMEM/50% RPMI. MEFs from fancd2/
and their WT counterpart mice [19], SV40 transformed human
ﬁbroblasts MRC5VA, XP12RO, XP129 [20] and HeLa were cultured
in DMEM. All human cell lines were authenticated by STR proﬁling.
Media were supplemented with 10% fetal calf serum. Survival was
determined by MTT assays or by clonal survival. Cells were treated
with nucleosides for 18 or 48 h, washed and UVA irradiated in PBS.
For MMT assays, they were then seeded in normal medium into
96-well plates (500 cells/well) and the fraction of viable cells
was assayed 7–10 days later. For clonal survival, treated cells were
seeded into 6-well plates (300 cells/well) and colonies counted
10 days later. Each determination was performed in triplicate
and experiments were repeated at least twice.
2.3. UVA irradiation
Cells were irradiated in PBS with a UVH 253 lamp (UV Light
Technology, Ltd.) with a maximum output of 100 mW/cm2 at the
source outlet. Emission wavelengths ranged from 320 to 400 nm
with a maximum at 365 nm.
2.4. Analysis of photoproducts
2’-Deoxyribonucleosides were separated by HPLC on a Waters
Symmetry C18 Reverse Phase column as described [21].
Thiodeoxyribonucleosides, which all maximally absorb at around
340 nm, were quantiﬁed by their absorbance at 342 nm (A342);
dT, BrdU and dU were quantiﬁed by A260. To analyse photoprod-
ucts generated in vivo, MEFs were grown in the presence of
100 lM nucleoside for 48 h and UVA irradiated. Genomic DNAwas extracted using the Wizard Genomic DNA puriﬁcation kit
(Promega). Puriﬁed DNA was digested to nucleosides with nucle-
ase P1 followed by shrimp alkaline phosphatase as described [22].
SdU, BrdU and dU were identiﬁed by comparison to authentic
standards.
2.5. FANCD2 immunoblotting
Cell extracts (50 lg protein) were separated on 3–8% Tris-Ac-
etate gels (Invitrogen) and transferred to Immobilon-P membranes
(Millipore), which were probed with anti-FANCD2 antibody (Novus
Biologicals). Antigen-antibody complexes were detected by ECL
blotting detection reagent (GE Healthcare).
2.6. Comet assay
Alkaline comet assays were performed as described [23] on
HeLa cells that had been grown for 48 h in the presence of SIdU
or SBrdU and UVA irradiated. Targets of the uracil (UNG) or
OGG1 DNA glycosylases were revealed by washing cell lysates
three times with glycosylase reaction buffer and then incubating
them with UNG (Trevigen) (1 unit/50 ll buffer per slide for 1 h at
37 C) or OGG1 (Trevigen) (2 units/50 ll buffer per slide for 1 h
at 37 C) before electrophoresis. Control slides were treated with
buffer alone.
DNA crosslinking was assayed by treatment with 15 Gy c-ra-
diation prior to UVA irradiation. Additionally, cells were washed
three times with TE, pH 8.0 after lysis and then incubated with
1 mg/ml Proteinase K (Roche) in TE for 2 h at 37 C. All comets
were analysed using the Comet IV software.
2.7. Repair of UVC photoproducts
Cells were irradiated with 10 J/m2 UVC delivered from a UV
Stratalinker 2400 (Stratagene). Immediately after irradiation,
DNA was extracted using the QIAamp DNA Mini kit (Qiagen).
Pyrimidine(6-4)pyrimidone (6-4 Py:Py) photoproducts were anal-
ysed by ELISA, using the 6-4 Py:Py photoproduct antibody (Cos-
moBio) according to the manufacturer’s instructions.
2.8. DNA protein crosslinks
DNA protein crosslinking was analysed using a modiﬁed proto-
col of the Wizard genomic DNA puriﬁcation kit (Promega). Brieﬂy,
cells grown in the presence of SIdU or SBrdU for 48 h were UVA
irradiated. Whole cell extracts were prepared, digested with RNAse
A and incubated overnight at 50 C with 100 lg/ml Proteinase K.
Control extracts were incubated in the absence of Proteinase K.
Residual protein was removed by precipitation and DNA recovered
by isopropanol precipitation according to the manufacturer’s
instructions. DNA concentrations were measured using a Nano-
Drop spectrophotometer (LabTech).
2.9. In vitro crosslinking
Oligodeoxynucleotides were obtained from atdbio.
5’-GAATCAGCCTGCACAGATACGAG-3’
5’-GAATCAGCCSGCACAGATACGAG-3’
5’-GAATCAGCTSGCACAGATACGAG-3’
5’-GAATCAGCGSTCACAGATACGAG-3’
S = SdU
Complementary strands that placed A or inosine opposite SdU
were 5’end-radiolabelled with [32P] ATP (Perkin Elmer) using T4
polynucleotide kinase (New England Biolabs) and annealed in
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were UVA irradiated (50 kJ/m2), heat denatured and the products
analysed by electrophoresis on 16% polyacrylamide gels.3. Results
3.1. UVA photosensitisation
SBrdU and SIdU are incorporated into DNA of growing cells and
sensitise them to killing by UVA. Following growth of HeLa cells for
48 h in medium containing 100 lM SBrdU, the thionucleoside
replaced between 0.045% and 0.06% of DNA thymidine in three
independent experiments. Under the same conditions, SIdU substi-
tution was between 0.025% and 0.033%. The approximately two-
fold higher incorporation of SBrdU was maintained over a range
of nucleoside concentrations. These levels of DNA substitution
were not detectably toxic but caused signiﬁcant UVA sensitivity
(Fig. 1). Despite lower incorporation, SIdU was a more effective
UVA photosensitiser than SBrdU. Photosensitisation required the
pyrimidine thiol group and neither BrdU nor IdU potentiated
UVA toxicity even at 10-fold higher levels of DNA substitution
(Fig. 1). DNA SIdU and SBrdU were also UVA photosensitisers in
the human HaCaT keratinocyte cell line (data not shown). The
observed toxicity arises predominantly from incorporated SIdU or
SBrdU rather than intracellular nucleoside/nucleotide pools and
cell survival was largely unchanged by up to six-hours growth in
normal medium to deplete unincorporated thionucleosides prior
to UVA irradiation (Supplementary Fig. 1).
3.2. Potentially lethal DNA photoproducts
3.2.1. DNA–protein crosslinks (DPCs)
DNA-protein crosslinking by UVC irradiation of DNA containing
BrdU or IdU is an established method to study nucleoproteinFig. 1. SIdU/UVA and SBrdU/UVA sensitivity. Survival: HeLa cells were grown in the
presence of SIdU, SBrdU (50 or 100 lM), IdU (250 lM) or BrdU (125 lM) for 48 h
and then UVA irradiated as indicated. Survival was assessed by colony formation.
Because nucleoside incorporation varied somewhat between experiments resulting
in different absolute survival values, a representative experiment (of three) is
shown.complexes [24]. DNA-protein crosslinks (DPCs) are particularly
challenging to cellular DNA repair systems and are potentially
lethal. DPC formation after SIdU/UVA or SBrdU/UVA treatment
was investigated by a DNA puriﬁcation protocol that includes a
precipitation step at which DPCs co-precipitate with protein. This
reduces DNA recovery. DNA recovery is restored if protease diges-
tion precedes precipitation. Lysates prepared from SIdU/UVA- or
SBrdU/UVA-treated cells were divided into equal parts one of
which was extensively digested with Proteinase K. DNA was then
precipitated. UVA irradiation reduced DNA yields from SIdU- or
SBrdU-treated cells in a dose-dependent fashion (Supplementary
Fig. 2, Fig. 2A). Proteinase K digestion reversed the DNA losses indi-
cating the presence of DPCs. The formation of DPCs in SIdU/UVA
and SBrdU/UVA cells was conﬁrmed by comet assays (see below).3.2.2. DNA interstrand crosslinks
UVC activation of DNA IdU or BrdU induces ICLs [8,9]. The alka-
line comet assay detects ICLs by their reduced comet tail moments
following c-irradiation. In combination with protease digestion,
this assay also detects the presence of DPCs. Fig. 2B shows that
SIdU/UVA and SBrdU/UVA treatment reduced comet tail moments,
consistent with the formation of ICLs and/or DPCs. Proteinase K
digestion prior to electrophoresis increased the comet tail moment
conﬁrming that both SBrdU/UVA and SIdU/UVA induce DPCs. Pro-
tease digestion did not fully restore tail moments to untreated val-
ues indicating that both SBrdU/UVA and SIdU/UVA also induce
ICLs.
Cells process ICLs by the Fanconia anemia (FA) pathway [25]
and FA cells are exquisitely sensitive these lesions. ICLs trigger
monoubiquitination of the FANCD2 protein – a key step in FA path-
way activation. UVA irradiation of SIdU- or SBrdU-treated HeLa
cells induced robust FANCD2 modiﬁcation (Fig. 2C), conﬁrming
that both treatments produced ICLs. To determine whether ICLs
contribute to SIdU and SBrdU phototoxicity, we examined the sen-
sitivity of FANCD2-defective MEFs. Fig. 2D shows that FANCD2/
cells are more sensitive than their FANCD2+/+ counterparts. These
ﬁndings implicate ICLs in the cytotoxicity of SIdU/UVA and
SBrdU/UVA.3.2.3. DNA strand breaks and uracil DNA glycosylase substrates
The alkaline comet assay was used to investigate the induction
of single-strand DNA breaks and/or alkali-labile sites. Fig. 3A shows
that both SIdU and SBrdU potentiated UVA-dependent increases in
comet tail moment consistent with the induction of single-strand
breaks/alkali-labile sites. Digestion with uracil DNA glycosylase
(UNG) prior to electrophoresis caused a further increase in comet
tail moment indicating that both treatments generate UNG sub-
strates. No DNA breakage was detected when UNG digestion was
combined with SIdU, SBrdU or UVA treatment alone, indicating
that UNG substrates are UVA photoproducts of SIdU/SBrdU. In par-
allel experiments, pulse-ﬁeld gel electrophoresis revealed that nei-
ther SIdU/UVA nor SBrdU/UVA induced detectable DNA double-
strand breakage (data not shown).
The contribution of the UNG-susceptible DNA lesions to SIdU/
UVA and SBrdU/UVA toxicity was examined by comparing the sen-
sitivity of UNG-proﬁcient or -deﬁcient MEFs. Fig. 3B shows that the
UNG substrates generated by these treatments differ in their
potential toxicity. UNG-deﬁcient cells were more sensitive to
SBrdU/UVA than their UNG proﬁcient counterparts (Fig. 3B, left
panel). In contrast, SIdU/UVA was equitoxic to both UNG-proﬁcient
and -deﬁcient cells (Fig. 3B, right panel). This differential toxicity
indicates that SBrdU/UVA induces potentially lethal lesions which
are excised by UNG whereas UNG substrates produced by SIdU/
UVA would not contribute signiﬁcantly to toxicity.
Fig. 2. Crosslink formation and cell sensitivity. (A) DNA-protein crosslinks: HeLa cells were grown for 48 h in the presence of SIdU or SBrdU as indicated and irradiated with 0,
25 or 50 kJ/m2 UVA. Cells were lysed immediately after irradiation. Equal amounts of lysate were incubated overnight at 50 C in the presence (+Prot K) or absence (Prot K)
of Proteinase K. Proteins were then precipitated and discarded. DNA recovered from the supernatant was quantiﬁed. Data are expressed as a percentage of recovery from
unirradiated cells and are representative of three independent determinations. (B) Crosslink formation – comet assay: HeLa cells grown in the presence of 100 lM SIdU or
SBrdU for 48 h were UVA irradiated (20 kJ/m2). They were then c-irradiated with 15 Gy and analysed by the alkaline comet assay either immediately after irradiation or
following Proteinase K digestion as indicated. DNA breakage is expressed as comet tail moment. (C) FANCD2 activation: HeLa cells that had been treated for 24 h with 25 lM
SIdU or SBrdU were irradiated with the indicated UVA doses. 2 h after irradiation, cell extracts were analysed by western blotting with FANCD2 antibody. The positions of
FANCD2 and its monoubiquitinated form (⁄) are indicated. (D) Sensitivity of Fanconi anemia defective cells: FancD2-proﬁcient (WT) and -deﬁcient (FANCD2) MEFs were
grown for 18 h in the presence of 5 lM SIdU (left panel) or 10 lM SBrdU (right panel) to obtain similar levels of DNA substitution. Following UVA-irradiation at the indicated
doses, survival was assessed by colony formation. A representative experiment (of three) is shown.
4 R. Brem et al. / Journal of Photochemistry and Photobiology B: Biology 145 (2015) 1–103.2.4. Nucleotide excision repair substrates
SIdU and SBrdU are analogs of 4-thiothymidine (S4TdR) which
generates thietane intrastrand crosslinks with an adjacent DNA
thymine when activated by UVA [26,27]. Thietanes are intermedi-
ates in the formation of lesions that resemble canonical 6-4 Py:Pynucleotide excision repair (NER) substrates and that compete for
removal by this pathway [27]. To examine the effect of photoacti-
vated SIdU and SBrdU on NER, SIdU- or SBrdU-treated HeLa cells
were irradiated with UVA and a low dose of UVC. The removal of
the UVC-induced 6-4 Py:Pys was then analysed by ELISA. Fig. 3C
Fig. 3. DNA strand breaks, UNG substrates and NER. (A) Comet assays: HeLa cells were treated with 100 lM SIdU (left panel) or SBrdU (right panel) for 48 h and UVA
irradiated. DNA strand breaks and/or abasic sites were determined by single cell electrophoresis with or without digestion with recombinant UNG as indicated. (B) Sensitivity
of ung/ MEFs: UNG-proﬁcient (WT) and -deﬁcient (UNG) cells were grown in the presence of SBrdU (5 and 30 lM, respectively; left panel) or SIdU (10 and 60 lM; right
panel) for 24 h to ensure equal levels of DNA substitution (0.025% for SBrdU,0.022% for SIdU). They were UVA irradiated and survival was determined 7 days later by MTT
assay. (C) 6:4 Py:Py excision: HeLa cells grown in 200 lM SIdU or 300 lM SBrdU for 48 h were irradiated as indicated with 20 kJ/m2 UVA followed by 20 J/m2 UVC and
returned to normal growth medium. DNA was extracted at the times indicated and 6-4 Py:Py photoproducts were quantiﬁed by ELISA. (D) Sensitivity of NER-defective cells:
MRC5VA (NER-competent), XP12RO (XPA, NER-deﬁcient) and XP129 (NER proﬁcient XP ‘revertant’) cells were incubated with 120 lM SBrdU (left panel) or SIdU (right panel)
for 72 h and UVA irradiated. Survival was measured by MTT assay 10 days later. In the absence of drug treatment, survival of all three cell lines was >90% at all UVA doses
used. In the experiment shown (representative of two), DNA substitution by the three cell lines was similar at 0.035% of TdR for SBrdU and 0.02% for SIdU.
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untreated cells, 6-4 Py:Pys were excised with a half-life of
approximately 60 min and only 5% remained after 2 h. SIdU/UVA
or SBrdU/UVA treatment increased the half-life of 6-4 Py:Py photo-
products to around 75 min and 20% remained after 2 h. To examine
whether SIdU/UVA and SBrdU/UVA induced competing NER sub-
strates, we compared the sensitivity of NER wild-type (MRC5VA),
NER-deﬁcient XP (XP12RO) and XP12RO ‘‘revertant’’ XP129 cells.
XP129 cells have regained the ability to repair 6-4 Py:Pys but not
other potentially lethal UV photoproducts [20]. XP12RO cells were
sensitive to both SIdU/UVA and SBrdU/UVA consistent with theintroduction of potentially lethal NER substrates. In contrast,
XP129 were almost as resistant as NER-proﬁcient MRC5VA cells
(Fig. 3D). The relative resistance of XP129 cells to both SIdU/UVA
and SBrdU/UVA indicates that both treatments induce potentially
lethal DNA photoproducts that resemble canonical UVC 6-4 Py:Py
photoproducts and are excised by NER.
3.3. Collateral DNA damage and singlet oxygen
It is well established that UVA irradiation of cells generates
singlet oxygen (1O2) via reactions that are enhanced by
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ine whether SBrdU and SIdU photosensitization involved a Type
II component, SBrdU and SIdU treated cells were UVA irradiated
in D2O which extends the half-life of 1O2 and increases the like-
lihood of reaction. The alkaline comet assay (Fig. 4A) indicated
that irradiation in D2O caused a reduction in IR-induced comet
tail moments. Since all samples were extensively Proteinase K
digested prior to electrophoresis, these ﬁndings indicate that
ICL formation by SIdU/UVA and SBrdU/UVA is at least partially
dependent on 1O2.
Alkaline comet assays with OGG-1 digestion were used to
detect DNA 8-oxoguanine (8-oxoG), a common DNA lesion and a
sensitive marker of oxidative DNA damage. Fig. 4C indicates that
neither SBrdU/UVA nor SIdU/UVAmeasurably increased DNA 8-ox-
oG over the low levels induced by UVA irradiation alone. In control
experiments, DNA 8-oxoG levels were signiﬁcantly increased by
treatment with KBrO3. Thus, although their effects are partially
dependent on 1O2, highly toxic SBrdU/UVA and SIdU/UVA combi-
nations do not produce widespread collateral damage in the form
of oxidised guanine.3.4. SIdU and SBrdU photoproducts – in vitro identiﬁcation
Reverse phase HPLC was used to investigate the photochemical
reactions of SIdU and SBrdU. Where appropriate, photoproducts
were identiﬁed by comparison with authentic compounds.Fig. 4. Singlet oxygen production and oxidation of DNA. (A) Singlet oxygen and ICL for
incubated for 1 h in PBS made in H2O or D2O and then irradiated with UVA (20 kJ/m2) follo
K digestion. DNA breakage is expressed as comet tail moment. (B) Generation of 8-ox
irradiated. The presence of DNA 8-oxoguanine was revealed by single cell electrophoresi
experiment HeLa cells were treated with 10 mM KBrO3 for 1 h and analysed in the sam3.4.1. SIdU
UVA irradiation of SIdU in aqueous solution destroyed the
thionucleoside. Low UVA doses (20–40 kJ/m2) caused de-iodination
of SIdU to SdU (Fig. 5A and Supplementary Fig. 3). SdU yields were
not increased at higher UVA doses (40–160 kJ/m2). A second photo-
product, identiﬁed as dUwas generated at higher UVA doses consis-
tent with possible formation from SdU. Analysis of the irradiation
products of authentic SdU conﬁrmed this possibility. Fig. 5B shows
that dU accounts for most (>60%) of the SdU destroyed by UVA. In
addition to dU, a second photoproduct with absorbance at
342 nm eluted at 10.1 min. It was formed in a UVA dose-dependent
fashion between 0 and 80 kJ/m2 but was destroyed at the highest
UVA dose of 160 kJ/m2 (Fig. 5C). This photoproduct is a plausible
intermediate in the conversion of SdU to dU.
To examine whether the 10.1 min eluting material was an
oxidation product of SdU, SdU was treated in aqueous solution
with magnesium monoperoxyphthalate (MMPP), a mild oxidising
agent that selectively oxidises thiol-containing nucleobases [21].
The SdU/MMPP reaction was almost complete at equimolar nucle-
oside and oxidant concentrations (Fig. 5D) and generated a single
product with A342 eluting at 10.1 min that was destroyed at higher
MMPP concentrations (Fig. 5E). Its destruction was not accompa-
nied by the formation of other A342-absorbing products but coin-
cided with the formation of dU, which was detected by its A260.
We conclude that the 10.1 min eluting product contains an oxi-
dised thiol group and is an intermediate in the conversion of SdU
to dU.mation: HeLa cells grown in the presence of 200 lM SIdU or SBrdU for 48 h were
wed by 15 Gy c-rays. Analysis was by the alkaline comet assay following Proteinase
oguanine: HeLa cells were treated with 100 lM SBrdU or SIdU for 48 h and UVA
s following digestion with recombinant OGG1 as indicated. Right panel: In a control
e way.
Fig. 5. UVA photoproducts of SIdU. (A–C) Photodestruction of SIdU: Aqueous solutions (100 lM) of SIdU (A) or SdU (B) were irradiated with the indicated doses of UVA.
Photoproducts were analysed by reverse phase HPLC with 260 nm and 342 nm detection. Each product was quantiﬁed by comparison to authentic standards. Data are
expressed as Mole% of the unirradiated input nucleoside. For the unidentiﬁed product SIdU irradiation product eluting at 10.1 min (panel C), values are expressed as A342 peak
area (lV  s). Traces corresponding to (A) are shown in Supplementary Fig. 3. (D and E) MMPP oxidation: SdU (100 lM) in solution was treated with MMPP for 20 min at the
indicated molar ratios and analysed by HPLC as above. (F) Photodestruction of DNA SIdU: HeLa cells that had been grown in 100 lM SIdU for 24 h and in which SIdU replaced
approximately 0.03% of DNA TdR were UVA irradiated at the indicated doses. DNA was extracted, digested to nucleosides and analysed by HPLC as in A. (G) Crosslink
formation in vitro – gel migration assay: Radiolabelled 23mer oligonucleotide duplexes containing a single SdU(S):A or: I base pair were irradiated with 50 kJ/m2 UVA.
Products were heat denatured and resolved on a 16% polyacrylamide gel. The 5’ and 3’ bases ﬂanking the SdU are shown above the corresponding lane in the gel image. The
position of migration of crosslinked duplexes is indicated.
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sistent with those of the free nucleoside. HPLC analysis of nucle-
oside digests of DNA extracted from irradiated SIdU-treated cells
revealed that UVA also destroys DNA SIdU. Fig. 5F shows that
20 kJ/m2 UVA destroyed >60% of DNA SIdU and its disappearance
was complete between 40 and 80 kJ/m2. At low UVA doses
(20 kJ/m2) SdU accounted for about half of the DNA SIdU destroyed.
SdU levels were not signiﬁcantly increased by higher UVA doses,
but above 80 kJ/m2 measurable amounts of dU were generated,
most likely as an SdU photoproduct. The formation of DNA dU in
these experiments is consistent with the observation (Fig. 3B) that
UVA activation of DNA SIdU in intact cells generates low levels of a
non-toxic substrate for the UNG DNA glycosylase.This analysis identiﬁes SdU as a plausible intermediate in the
photochemical destruction of DNA SIdU. Since SdU can be built
into synthetic oligonucleotides and ICLs are a signiﬁcant photopro-
duct in SIdU/UVA treated cells, we examined whether DNA SdU
could participate in UVA-mediated ICL formation in vitro. Oligonu-
cleotide duplexes containing a single SdU paired with a comple-
mentary A were UVA irradiated and the products analysed by
denaturing gel electrophoresis. We observed the SdU/UVA-depen-
dent formation of slowly-migrating products with characteristics
of crosslinked duplexes (Fig. 5G). Crosslinking was inﬂuenced by
local sequence. ICL formation was more efﬁcient when SdU was
ﬂanked by a 5’ pyrimidine and 3’G than when the ﬂanking bases
were 5’G/3’T. The amino group of the complementary A was
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ble-paired inosine even signiﬁcantly enhanced ICL formation.
In summary, the formation of DNA dU and ICLs that we inferred
from experiments with living cells can be recapitulated by UVA
irradiation of SIdU or DNA SIdU in vitro. The formation of these
photoproducts depends on an initial deiodination of SIdU.3.4.2. SBrdU
UVA also destroyed SBrdU in aqueous solution (Fig. 6A and Sup-
plementary Fig. 4). SBrdU disappearance coincided with the forma-
tion of a photoproduct with 342 nm absorbance and a retention
time of 18.7 min (Fig. 6B). Higher UVA doses (160 kJ/m2) destroyed
this photoproduct with the concomitant formation of low, but
detectable levels of BrdU (Fig. 6A). Importantly, SdU was not
detected indicating that UVA irradiation does not cause SBrdU
debromination. The photoproduct eluting at 18.7 min was an
oxidation product of SBrdU and it was generated by treatment with
MMPP (Fig. 6C and D). Oxidation of SBrdU coincided with the for-
mation of BrdU as the only detectable UV-absorbing product. At
the highest MMPP concentration, BrdU accounted for P60% of
the initial SBrdU with a small residual amount of the intermediate.
The behaviour of DNA SBrdU differed signiﬁcantly from that of
the free nucleoside. In irradiated HeLa cells approximately 40% of
DNA SBrdU was destroyed at the lowest UVA dose (20 kJ/m2)
(Fig. 6E). The residual DNA SBrdU was relatively UVA resistant
and approximately 50% remained even after 120 kJ/m2 UVA. SdU
was not observed indicating that debromination occurred infre-
quently, if at all.Fig. 6. Photooxidation of SBrdU. (A and B) Photodestruction: An aqueous solution (100
separated by HPLC and monitored at 260 and 342 nm. Products were quantiﬁed by com
SBrdU. For the unidentiﬁed SBrdU irradiation product eluting at 18.7 min (panel B), value
Supplementary Fig. 4. (C and D) MMPP oxidation: An aqueous solution of SBrdU (100 lM
HPLC as above. (E) Photodestruction of DNA SBrdU: Cells that had been grown in 100 lM
UVA irradiated at the indicated doses. DNA was extracted, digested to nucleosides and
recovered SBrdU is expressed as percentage SBrdU in DNA from unirradiated cells.In summary, the in vitro photochemical properties of SIdU and
SBrdU are consistent with the formation of DNA damage that we
infer from in vivo experiments. In particular, they deﬁne possible
routes for dU and ICL formation by DNA SIdU/UVA. The reactions
of SBrdU/UVA are different and do not involve loss of the Br atom.4. Discussion
The halopyrimidine 2’-deoxynucleosides BrdU and IdU are
acknowledged ionising radiation and UVB sensitisers. In the pres-
ence of DNA-intercalated Hoescht 33258 dye they also sensitise
the formation of lethal DNA damage by UVA [29,13]. We have pre-
viously characterised SIdU [17] and SBrdU [16]. Here we show that
both cause lethal DNA photodamage in human cells. The presence
of the pyrimidine thiol group obviates the need for a separate
intercalated UVA chromophore and UVA irradiation of cells con-
taining DNA-embedded halogenated thiopyrimidines generates
potentially cytotoxic DNA lesions.
SBrdU was more extensively incorporated into DNA than SIdU
but the latter was a more effective photosensitiser at equivalent
levels of DNA substitution. The dissimilar effectiveness of DNA SIdU
and SBrdU probably reﬂects the relative ease of dehalogenation.
UVA-induced deiodination of SIdU is favoured in free solution and
in DNA. The resulting thiouracil-5-yl radical can be converted to
SdU, one of the photoproducts we identiﬁed. In DNA, thiouracil-5-
yl radicals can abstract hydrogen from 2’-deoxyribose to generate
single-strand breaks [6]. Theymay also reactwith nearby functional
groups of DNA or proteins to form the ICLs and DPCs that arelM) of SBrdU was irradiated with the indicated doses of UVA. Photoproducts were
parison to authentic standards and data are expressed as Mole% of the unirradiated
s are expressed as A342 peak area (lV  s). Traces corresponding to (A) are shown in
) was treated with MMPP for 20 min at the indicated molar ratios and analysed by
SBrdU for 24 h and in which SBrdU replaced approximately 0.06% of DNA TdR were
analysed by HPLC as in A. As SBrdU was the only nucleoside detected at 342 nm,
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bond of SBrdU is more stable. Debromination is less favoured and
SdUwas not a detectable photoproduct of SBrdU either in free solu-
tion or in DNA. In this regard, UVA activation of DNA SBrdU differs
signiﬁcantly from UVB photosensitisation of DNA BrdU and UVA/
dye/DNA BrdU reactions both of which generate DNA uracil [6,13].
The thiol group of the thionucleosides is also a potential oxida-
tion target [30]. Selective oxidation of SdU and SBrdU thiol groups
by MMPP yielded intermediates that retained 342 nm absorbance
and underwent further oxidation to products that no longer
absorbed UVA. These oxidised thiols are reactive and the UVA-in-
duced generation of dU and BrdU from SdU and SBrdU, respective-
ly, is consistent with the hydrolytic loss of an oxidised S4 atom. The
yields of DNA dU and DNA SdU from cells treated with SIdU/UVA
were not, however, stoichiometric. SdU levels were not related to
UVA dose and its disappearance was not quantitatively accounted
for by conversion to dU. We speculate that reactions between oxi-
dised nucleobase thiols and functional groups of other DNA nucle-
obases or proteins is favoured over hydrolysis. These preferred
reactions to generate ICLs and DPCs, are also consistent with our
observation that BrdU is undetectable in DNA SBrdU/UVA treated
cells.
Using cell lines with deﬁned defects in DNA repair, we identiﬁed
several potentially cytotoxic DNA SIdU and SBrdU photoproducts.
These included ICLs and the hypersensitivity of FANCD2-deﬁcient
cells to both SBrdU/UVA and SIdU/UVA emphasizes the important
contribution of ICLs to toxicity. ICLs have a high probability of being
lethal. Their formation is advantageous in photochemotherapy and
the therapeutic effectiveness of PUVA, for example, reﬂects efﬁcient
ICL induction. Signiﬁcantly, FANCD2 monoubiquitination – an indi-
cator that the cellular response to ICLs has been engaged – occurs
following mild treatment with SIdU/UVA or SBrdU/UVA indicating
that ICLs are likely to be abundant and a major contributor to leth-
ality. Our experiments demonstrated that UVA photochemically
crosslinks oligodeoxyribonucleotides via SdU, an identiﬁed DNA
SIdU photoproduct. ICL formation was enhanced by a less stable
structure conferred by a complementary inosine and by the pres-
ence of C ﬂanking the complementary base. In folded tRNA, 4-
thiouridine (SrU), a naturally-occurring minor base at the unpaired
position 8, undergoes UVA-mediated crosslinking to cytosine 13
[31] and it seems plausible that SdU is an intermediate in UVA-me-
diated ICL formation from DNA SIdU.
Treatment of cells with SIdU/UVA or SBrdU/UVA generated
lesions that are substrates for removal by UNG-mediated base
excision repair. In the case of SBrdU/UVA, these substrates are
potentially lethal. Because UNG has to discriminate DNA uracil
from thymine, SBrdU photoproducts that retain the Br atom are
unlikely to be recognised by UNG. This suggests that SBrdU must
undergo debromination to generate a substrate for UNG. SBrdU
debromination was below our level of detection by HPLC and so
the precise nature of these potentially lethal DNA lesions remains
to be determined. UNG/ cells were not sensitive to SIdU/UVA, a
treatment that generates DNA dU. This observation is consistent
with the known properties of DNA dU. Rare incorporation of DNA
uracil generates DNA dU:dA base pairs. These base pairs are well
tolerated even if they are not excised and UNG-defective cells in
which they persist, proliferate normally [18]. For the same reasons,
SdU, another potential target for excision by UNG that also pairs
well with adenine is unlikely to contribute to toxicity.
The SIdU/UVA and SBrdU/UVA hypersensitivity of NER-defec-
tive XP12RO cells is consistent with the formation of potentially
cytotoxic intrastrand crosslinks that distort DNA in a similar fash-
ion to UV-induced 6-4 Py:Py photoproducts [32,27]. This possi-
bility is strengthened by the almost wild-type SIdU/UVA and
SBrdU/UVA sensitivity of ‘revertant’ XP129 cells. In NER proﬁcient
cells, 6-4 Py:Py photoproducts are excised very rapidly and aregenerally considered to contribute less to the toxicity of UV radia-
tion than other photoproducts. Rapid excision by NER will tend to
minimise contribution of 6-4 Py:Py analogs to SIdU/UVA and
SBrdU/UVA toxicity.
UVB radiation induces protein-tRNA crosslinking via SrU
[33,31]. Our experiments show that an analogous reaction involv-
ing DNA SdU generated by UVA-induced deiodination of SIdU con-
tributes to DPC formation. Although we cannot exclude the
participation of rare debrominated forms, the properties of DNA
SBrdU are consistent with the possible involvement of thiol oxida-
tion in DPC formation. The products of MMPP-induced thiol oxida-
tion of SIdU and SBrdU appeared identical to intermediates in their
photochemical destruction. In addition, ICL yields were increased
by irradiation in D2O, implicating 1O2 in ICL formation. Oxidised thi-
ols, sulﬁnate and sulfonates are good leaving groups in nucleophilic
substitution reactions and the UVA-induced generation of dU and
BrdU from SdU and SBrdU, respectively, is consistentwith oxidation
and hydrolytic loss of the S4 atom. These oxidised forms of SIdU and
SBrdU are plausible intermediates in ICL formation via reaction
with functional groups in DNA-associated proteins. In view of the
involvement of 1O2 in the photochemical effects of DNA SIdU and
SBrdU, it is surprising that we did not observe signiﬁcant levels of
DNA 8-oxoG as collateral damage. Although we have not examined
this point experimentally, we speculate that the photochemically-
generated 1O2 might react preferentially with DNA SIdU or SBrdU
and thereby attenuate the threat to DNA guanine.
UVA activation of DNA thiopyrimidines has therapeutic poten-
tial. S4TdR/UVA eradicated cancer in an orthotopic bladder carcino-
ma model in rats [34]. Nucleoside salvage enzymes like thymidine
kinase are frequently upregulated in tumours suggesting that sys-
temically administered SIdU or SBrdU may selectively target
tumour cells. Indeed, radio-iodine-containing IdU preferentially
localises to tumours in mice [35]. Exogenous nucleosides such as
SIdU and SBrdU must compete with endogenous pools of thymi-
dine nucleotides for incorporation into DNA. We note in this regard
that treatment with the thymidylate synthase inhibitor tomudex
(Raltitrexed) that reduces the size of intracellular thymidine pools,
increases the DNA accumulation of S4TdR [34], the direct analog of
SIdU and SBrdU. Co-treatment of SIdU or SBrdU with tomudex
would offer a straightforward way to improve UVA sensitisation
and therapeutic effectiveness. Thiopyrimidine phototoxicity is
dependent on the induction of potentially lethal DNA damage
and DPCs and ICLs are likely to be major contributors. These DNA
lesions are challenging to cellular DNA repair systems and suggest
that UVA photoactivation of DNA SIdU or SBrdU would be an effec-
tive therapeutic strategy.
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